‘Systemic leap’: China’s drug innovation push yields bumper crop
AdvertisementChina’s private sectorBusinessChina Business ‘Systemic leap’: China’s drug innovation push yields bumper crop Home-grown therapies account for 80 per cent…
Your Compass for Current News
AdvertisementChina’s private sectorBusinessChina Business ‘Systemic leap’: China’s drug innovation push yields bumper crop Home-grown therapies account for 80 per cent…
AdvertisementBanking & financeBusinessChina Business Mainland China funds increase stakes in Hong Kong biotech amid surge of licensing deals Analysts say…
AdvertisementChina’s private sectorBusinessChina Business China’s drug industry pivots to AI-powered candidates to drive next wave of deals China develops 30…
AdvertisementChina’s private sectorBusinessChina Business China AI drug-design deals swell as US scrutiny mounts Global pharmaceutical firms are tapping into Chinese…
AdvertisementChina’s private sectorBusinessChina Business Which company could become the Chinese Pfizer? Here are analysts’ top picks A boom in outlicensing…
The artist Tracey Emin has spoken about the impact on her life of surgery she received after a diagnosis of…